Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127560831 | 12756083 | 1 | I | 20071004 | 20071005 | 20160916 | 20160916 | PER | US-ASTRAZENECA-2007BM16656 | ASTRAZENECA | 20180.00 | DY | F | Y | 90.70000 | KG | 20160916 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127560831 | 12756083 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | N | U | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
| 127560831 | 12756083 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | N | U | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
| 127560831 | 12756083 | 3 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | N | U | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
| 127560831 | 12756083 | 4 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | FN0081 | 0 | 2 | MG | /wk | |||||||
| 127560831 | 12756083 | 5 | C | DRUG USED IN DIABETES | UNSPECIFIED INGREDIENT | 1 | Unknown | UNK | 0 | ||||||||||
| 127560831 | 12756083 | 6 | C | GLUCOTROL | GLIPIZIDE | 1 | Unknown | 0 | 10 | MG | QD | ||||||||
| 127560831 | 12756083 | 7 | C | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | 1000 | MG | BID | ||||||||
| 127560831 | 12756083 | 8 | C | ALTACE | RAMIPRIL | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127560831 | 12756083 | 1 | Type 2 diabetes mellitus |
| 127560831 | 12756083 | 2 | Type 2 diabetes mellitus |
| 127560831 | 12756083 | 3 | Type 2 diabetes mellitus |
| 127560831 | 12756083 | 4 | Type 2 diabetes mellitus |
| 127560831 | 12756083 | 5 | Type 2 diabetes mellitus |
| 127560831 | 12756083 | 6 | Type 2 diabetes mellitus |
| 127560831 | 12756083 | 7 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127560831 | 12756083 | Blood glucose increased | |
| 127560831 | 12756083 | Decreased appetite | |
| 127560831 | 12756083 | Drug ineffective | |
| 127560831 | 12756083 | Injection site erythema | |
| 127560831 | 12756083 | Injection site extravasation | |
| 127560831 | 12756083 | Injection site haemorrhage | |
| 127560831 | 12756083 | Injection site mass | |
| 127560831 | 12756083 | Injection site pruritus | |
| 127560831 | 12756083 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127560831 | 12756083 | 1 | 20071003 | 0 | ||
| 127560831 | 12756083 | 2 | 20081001 | 0 | ||
| 127560831 | 12756083 | 3 | 20160430 | 0 | ||
| 127560831 | 12756083 | 4 | 20160501 | 0 | ||
| 127560831 | 12756083 | 5 | 2007 | 20071004 | 0 |